Financial incentives play a significant role as health care accounts for nearly 20% of the American economy, attracting every major AI company to invest heavily in this sector.
Paul Martin Jensen and Avi Tuschman suggest that combating medical misinformation could be more effective if people were better equipped to recognize when they are being manipulated. Making this process easier could disrupt the current health misinformation business model.
Medicare's payment policy for hospitals using newly-approved AI devices may unintentionally encourage excessive use, according to researchers.
Commure is on a bold mission to streamline healthcare administration using AI technology. This inside perspective explores the complex challenges the startup faces as it works to automate the intricate and often chaotic business side of healthcare.
Former surgeon Frances Mei Hardin argues that AI itself is not to blame; rather, it acts as a reflection of the ongoing reduction in physician judgment and autonomy.
Federal health officials have organized private meetings with technology companies, researchers, and lobbyists to encourage greater adoption of clinical artificial intelligence in healthcare settings.
Leaders of the Federation of State Medical Boards share their perspectives on the emerging issue of whether artificial intelligence should be licensed to practice medicine. They explore the implications and challenges involved in governing AI within medical practice.
Medical educators encourage proficiency with AI scribes for future doctors but express concern about the impact of relying on AI for clinical documentation on educational outcomes.
Former VA Secretary David Shulkin highlights the powerful alliance of HHS, the VA, and the DOD as a uniquely American innovation hub that competitors like China find hard to match, emphasizing its potential to drive biotech advancement.
Congress is rushing to pass several important health care bills before its August recess, focusing on issues like price transparency and the streamlining of prior authorization processes.